CTT Pharmaceutical Holdings, Inc.
    SEC Filings

    |
    |

    All SEC filings by CTT Pharmaceutical Holdings, Inc. (CTTH) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.

    Financials

    10-QQuarterly reportView DiffNov 23, 2015
    10-Q/AQuarterly reportView DiffNov 18, 2015
    NT 10-QNotice of late quarterly filingNov 16, 2015
    10-Q/AQuarterly reportView DiffNov 12, 2015
    10-K/AAnnual reportView DiffOct 8, 2015
    10-QQuarterly reportView DiffAug 19, 2015
    NT 10-QNotice of late quarterly filingAug 14, 2015
    10-K/AAnnual reportView DiffJul 21, 2015
    10-K/AAnnual reportView DiffJun 9, 2015
    10-QQuarterly reportView DiffMay 22, 2015

    Events

    8-KCtt Pharma Receives U.s. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery TechnologyAug 12, 2026
    8-K/ADeparture of Directors or Certain OfficersFeb 24, 2016
    8-KDeparture of Directors or Certain OfficersFeb 11, 2016
    8-KNon-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim ReviewNov 3, 2015
    8-KAmendments to Articles of Incorporation or BylawsJul 30, 2015
    8-KDeparture of Directors or Certain OfficersJun 16, 2015
    8-K/ACompletion of Acquisition or Disposition of AssetsApr 22, 2015
    8-K/ACompletion of Acquisition or Disposition of AssetsMar 24, 2015
    8-K/ACompletion of Acquisition or Disposition of AssetsFeb 18, 2015
    8-K/ACompletion of Acquisition or Disposition of AssetsNov 28, 2014

    Registrations and Prospectuses

    S-1/AIPO registrationView DiffJul 24, 2026
    S-1/AIPO registrationView DiffJul 13, 2026
    S-1/AIPO registrationView DiffJun 29, 2026
    S-1/AIPO registrationView DiffJun 16, 2026
    S-1/AIPO registrationView DiffMay 29, 2026
    S-1/AIPO registrationView DiffApr 14, 2026
    S-1IPO registrationDec 30, 2025
    15-12GSecurities registration terminationMar 29, 2016
    SB-2Registration of securities for small business issuerFeb 1, 2008
    8-K12G3Changes in Registrant'S Certifying AccountantApr 8, 2002

    Proxies

    DEF 14CInformation statementJun 19, 2015
    PRE 14CPreliminary informationMay 29, 2015
    DEF 14ADefinitive proxyView DiffMay 3, 2012
    DEF 14ADefinitive proxyMay 31, 2011
    PRE 14APreliminary proxyMay 18, 2011
    DEF 14ADefinitive proxyView DiffJun 13, 2005
    DEF 14ADefinitive proxyView DiffJul 16, 2004
    PRE 14APreliminary proxyJun 28, 2004
    DEFA14AAdditional proxy soliciting materialsOct 9, 2003
    DEF 14ADefinitive proxySep 25, 2003

    Other

    EFFECTNotice of effectivenessAug 3, 2026
    UPLOADLetter from SECNov 30, 2015
    CORRESPCorrespondence with SECNov 5, 2015
    UPLOADLetter from SECOct 20, 2015
    CORRESPCorrespondence with SECOct 9, 2015
    UPLOADLetter from SECSep 29, 2015
    UPLOADLetter from SECJul 30, 2015
    UPLOADLetter from SECJun 24, 2015
    CORRESPCorrespondence with SECJun 9, 2015
    CORRESPCorrespondence with SECJun 3, 2015

    Ownership

    4Ctt Pharmaceutical Holdings, Inc.Sep 4, 2026
    4Ctt Pharmaceutical Holdings, Inc.Sep 2, 2026
    4Ctt Pharmaceutical Holdings, Inc.Aug 31, 2026
    4Ctt Pharmaceutical Holdings, Inc.Aug 24, 2026
    4Ctt Pharmaceutical Holdings, Inc.Aug 20, 2026
    4Ctt Pharmaceutical Holdings, Inc.Aug 19, 2026
    4Ctt Pharmaceutical Holdings, Inc.Aug 14, 2026
    4Ctt Pharmaceutical Holdings, Inc.Aug 14, 2026
    4Ctt Pharmaceutical Holdings, Inc.Aug 10, 2026
    4Ctt Pharmaceutical Holdings, Inc.Aug 10, 2026